Robert W. Arrington
Emeritus Professor
Also affiliated: Arkansas Children's Hospital (2000–2006); University of Arkansas Medical Center (1967–2019)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Robert W. Arrington's research has focused on various aspects of infant respiratory health and medical interventions. His publications include studies on congenital surfactant defects, the use of indomethacin for patent ductus arteriosus in newborns, and the resolution of pulmonary interstitial emphysema following intubation procedures. Arrington has also investigated the effects of radiation on the developing nervous system and the impact of head position on endotracheal intubation in neonates. His work includes exploring the efficacy of specific pharmacological agents, such as tolazoline HCl, as pulmonary vasodilators in hypoxemic newborn goats. Arrington's scholarship metrics include an h-index of 6, with a total of 7 publications and 185 citations.
Metrics
- h-index: 6
- Publications: 10
- Citations: 185
Positions
-
Emeritus Professor publications 1977–2019University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Resolution of pulmonary interstitial emphysema following selective left main stem intubation in a premature newborn: an old procedure revisited (2006)
-
Absence of Lamellar Bodies with Accumulation of Dense Bodies Characterizes a Novel Form of Congenital Surfactant Defect (2000)
-
1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS (1978)
Collaboration Network
Top Collaborators
- Resolution of pulmonary interstitial emphysema following selective left main stem intubation in a premature newborn: an old procedure revisited
- Resolution of pulmonary interstitial emphysema following selective left main stem intubation in a premature newborn: an old procedure revisited
- Absence of Lamellar Bodies with Accumulation of Dense Bodies Characterizes a Novel Form of Congenital Surfactant Defect
- Absence of Lamellar Bodies with Accumulation of Dense Bodies Characterizes a Novel Form of Congenital Surfactant Defect
- Absence of Lamellar Bodies with Accumulation of Dense Bodies Characterizes a Novel Form of Congenital Surfactant Defect
- Absence of Lamellar Bodies with Accumulation of Dense Bodies Characterizes a Novel Form of Congenital Surfactant Defect
- 1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS
- 1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS
- 1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS
- 1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS
- 1216 EFFICACY OF TOLAZOLINE HC1 AS A PULMONARY VASODILATOR IN NEWBORN HYPOXEMIC(Hyp) GOATS
Similar Researchers
Based on overlapping research topics